in this issue
Regions :: North America :: U.S.
Perrigo to acquire Irish biotechnology company Elan for $8.6 billion
9:00 AM MDT | July 29, 2013 | Deepti Ramesh
Health-care products firm Perrigo (Allegan, MI) and biotechnology company Elan (Dublin) say that they have entered into a definitive agreement under which Perrigo will acquire Elan for about $8.6 billion. At the close of the transaction, Perrigo and Elan will be combined under New Perrigo, a new company incorporated in Ireland. New Perrigo, which is expected to be called Perrigo Co. or a variant thereof, will be led by Perrigo’s current leadership team. The proposed transaction, which has been unanimously approved by the respective boards of directors of...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee